Results 251 to 260 of about 1,964,480 (312)

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

FEBS Open Bio, EarlyView.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart, Manon Van den Abbeel, Christoph Schifflers, Karim Bouhjar, Andrea Scarmelotto, Alexis Khelfi, Anne‐Catherine Wera, Carine Michiels   +7 more
wiley   +1 more source

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM. [PDF]

BJPsych Open
Beidas Z, Ragnhildstveit A, Blackman A, Anderson T, Fewster E, Syed OA, Sobolenko V, Kanca IK, Son T, Farb N, Petranker R.   +10 more
europepmc   +1 more source

Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET). [PDF]

J Neurooncol
Brehmer S, Sarria GR, Würfel S, Sulejmani A, Schneider F, Clausen S, Abo-Madyan Y, Ruder AM, Sperk E, Etminan N, Giordano FA.   +10 more
europepmc   +1 more source

A prospective phase II trial of 10-fraction whole-breast radiotherapy following breast-conserving surgery. [PDF]

Clin Transl Radiat Oncol
Xiang Y, Tie J, Zhang S, Shi C, Guo C, Peng Y, Liu Y, Wang W.   +7 more
europepmc   +1 more source

Liposomal doxorubicin plus nab-paclitaxel with/without chemoradiotherapy in head and neck adenoid cystic carcinoma: single-arm phase II study. [PDF]

Signal Transduct Target Ther
Zhang X, Wei J, Chen N, Liu K, Liang R, Ma L, Song Z, Gu X, Chen X, Yang S.   +9 more
europepmc   +1 more source

Camrelizumab Plus Nab-paclitaxel in Patients with Previously Treated Advanced Urothelial Carcinoma: A Multicenter Phase II Study. [PDF]

Cancer Commun (Lond)
Li H, Chen M, Huang R, Rong Q, Hao J, Zheng Q, Su Y, Shu D, Zhang Y, Yang W, Lei X, Cai Y, Xue C, An X, Shi Y.   +14 more
europepmc   +1 more source

Levosimendan in Cardiac Arrest (LeiCA): Protocol for a Randomized, Double-Blind, Phase II Clinical Trial. [PDF]

Acta Anaesthesiol Scand
Rysz S, Flam B, Hedberg M, Galmén K, Mårtensson J, Djärv T, Jonsson Fagerlund M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Phase II and You

AJN, American Journal of Nursing, 1972
Furthermore, regardless of their effect on inflation, control policies will affect different parts of the nation unevenly. A 5.5 percent pay increase will add $229 a year to a $2-an-hour poverty wage, or $11.000 to a $200,000 executive salary. Neither profits nor capital gains are controlled, and tax changes are most generous to business.
openaire   +2 more sources